THE KOREA SOCIETY

is a nonprofit, nonpartisan, 501(c)(3) organization with individual and corporate members that is dedicated solely to the promotion of greater awareness, understanding, and cooperation between the people of the United States and Korea. Learn more about us here.

  1. 0
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. 8
« »
  1. New
Friday, November 22, 2024 | 9:00 AM 
The Van Fleet Signature Policy Conference is The Korea Society’s landmark policy event. Held in the ...
cache/resized/11b4953fe652ba5174f7bd040d47b705.jpg
Thursday, December 5, 2024 | 6:00 PM 
Join us for an inspiring and heartwarming story timed for the holiday season about the largest ...
Tuesday, November 12, 2024 | 10:00 AM 
Join us for a conversation with Stephen Biegun, former U.S. Deputy Secretary of State and Special ...
Friday, November 8, 2024 | 12:00 PM 
Is South Korea on the verge of a nuclear breakout? Join us for a discussion about South Korea’s ...
Thursday, November 7, 2024 | 4:00 PM 
Join us for an expert discussion on the impact of intensifying competition on the U.S.-Korea ...
Tuesday, October 29, 2024 | 4:00 PM 
This program explores the historical and contemporary relationship between North Korea and Russia. ...
Friday, October 4, 2024 | 10:00 AM 
  Join us for a special conference on U.S.-Korea relations produced in partnership with the East ...
Tuesday, October 1, 2024 | 12:00 PM 
How can the U.S.-Korea Alliance rise to the challenge of an increasingly complex and fraught ...
Wednesday, September 25, 2024 | 4:30 PM 
Join us for a unique and special event highlighting the profound impact of North Korea's human ...
Tuesday, June 25, 2024 | 6:00 PM 
Join us for a conversation with Dr. Peter Banseok Kwon, Assistant Professor of Korean Studies at ...
Friday, June 28, 2024 | 10:30 AM 
Join us for a bipartisan pair of Former Members of Congress to hear a forecast unpacking how ...
 
By Samuel Orchard from Australia - BulguksaUploaded by Caspian blue, CC BY-SA 2.0, ...
 
A collection of our latest programs showcasing content on Korea and the impact of the novel ...
  1. Highlights
 
This program series aims to promote dialogue and awareness on Korean Peninsula peace and security ...
 
A curated collection of programs that mark the 70th anniversary of the start of the Korean War by ...
 
A collection of our latest programs showcasing content on Korea and the impact of the novel ...
 
The Korea Society’s Sherman Family Korea Emerging Scholar Lecture Award was established in 2017 ...

COVID-19 LESSONS FROM SOUTH KOREA: A Conversation Between Korea’s Top Coronavirus Expert Dr. Kim Woo Joo and Korea Society President Thomas Byrne

Media


Learn how South Korea managed to bring COVID-19 under control in this recorded interview between the Korea Society’s President, Thomas Byrne, and Professor of Infectious Diseases at Korea University Guro Hospital, Dr. Kim Woo Joo. Deemed by the media as South Korea’s “most prominent coronavirus expert”, Dr. Kim explains how he and the country learned from past epidemics to mobilize the public and private sectors to combat the novel coronavirus. Tune in to learn what lessons the U.S. and other countries can glean from South Korea’s successes.

 

COVID-19
LESSONS FROM SOUTH KOREA:
A Conversation Between Korea’s Top Coronavirus Expert
Dr. Kim Woo Joo and Korea Society President Thomas Byrne


The Korea Society
350 Madison Avenue, 24th Floor
New York, NY 10017

ABOUT THE SPEAKER:


Kim Woo Joo, M.D., Ph.D.

Professor,
Division of Infectious Diseases, Department of Internal Medicine,
Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea
 
Professor Kim Woo Joo is a native of Korea, where he received a Doctor of Medicine (Korea University College of Medicine, 1983) and was boarded in internal medicine (Korea University Hospital, 1987). In 1990, he joined the Division of Infectious Diseases of the Korea University Guro Hospital as a Clinical Instructor and achieved the subspecialty board of adult infectious diseases in 1992. From 1996 to 1997, he served as a visiting scholar at the Division of Infectious Diseases and Clinical Microbiology at Rush-Presbyterian St. Luke’s Medical Center, Chicago, USA. Between 1999 and 2001, he worked as Chief of the Laboratory of Respiratory Viruses and the National Influenza Center at the Korea National Institute of Health (KNIH), supervising the surveillance, control, and research activities concerning influenza, measles, rubella, and mumps. While at the KNIH, Professor Kim was instrumental in the establishment of the Korean Influenza Surveillance Scheme (KISS), the first such national surveillance system for influenza. Since 2000, Professor Kim has been a member of the National Advisory Committee on Influenza. He provides advice on issues such as the identification of priority groups for influenza vaccination programs, the appropriate vaccination campaign, surveillance, burden of disease studies, and vaccine safety. Since 2007, he also has been advising on the influenza pandemic preparedness plan that the Korea Centers for Disease Control and Prevention (KCDC) is developing, as well as the research and development of the influenza pandemic vaccine. In recognition of his expertise in and contribution to the field of influenza, he was appointed as Chair of the Trans-governmental Enterprise for Pandemic Influenza in Korea (TEPIK) in 2010, designated by the Ministry of Health and Welfare. He was the president of the Korean Society of Infectious Diseases from 2014 to 2015. During the 2015 MERS-CoV outbreak in Korea, he had served as the leader of Rapid Response Team and special supervisor to the prime minister to help the government contain the outbreak within two months. In the last five years, Professor Kim has published numerous articles in international journals, including the Lancet, Journal of Infectious Diseases, Vaccine, Clinical Vaccine and Immunology, PLoS One, Human Vaccines & Immunotherapeutics, Influenza and Other Respiratory Viruses, Emerging Infectious Diseases, Epidemiology and Infection, Scientific Reports, Journal of Clinical Virology and the Journal of Medical Virology.